期刊文献+

广泛子宫切除术的临床现状点评 被引量:1

Clinical Comment on Extensive Hysterectomy in Cervical Cancer Treatment
下载PDF
导出
摘要 广泛子宫切除术的临床应用已逾百年,在手术技巧、手术器械与辅助设备、无菌技术与麻醉技术等不断提高的基础上,手术路径从经腹腔、经阴道发展到经腹腔镜完成,手术创伤逐渐减少,而手术安全性也得到保证。根据手术范围的不同,广泛子宫切除术分为A、B两类,分别适宜不同临床分期宫颈癌的治疗。大量临床观察证实,在ⅠB~ⅡA期宫颈癌患者中,广泛子宫切除术与放疗的疗效相近。 It has been more than a century for extensive hysterectomy applied in cervical cancer treatment. With the development of surgical techniques, surgical instruments and auxiliary equipment, aseptic technique and anesthesia technology, surgical trauma is gradually reduced and safety are continuously improved based on the surgery path from completed by the abdomen and vagina to by laparoscopy. According to the different scope of operation, extensive hysterectomy is divided into A and B types which are suitable for different clinical stages of cervical cancer. Substantial clinical observation has confirmed that extensive hysterectomy has the similar efficacy to radiotherapy in stage ⅠB~ⅡA of cervical cancer.
出处 《国际妇产科学杂志》 CAS 2009年第2期87-89,共3页 Journal of International Obstetrics and Gynecology
关键词 宫颈癌 腹腔镜下广泛子宫切除术 经腹广泛性子宫切除术 放疗 Cervical cancer Laparoseopic extensive hysterectomy Laparotomy extensive hysterectomy Radiotherapy
  • 相关文献

参考文献10

  • 1Chen Y,Xu H,Li Y,et al.The outcome of laparoscopic radical hysterectomy and lymphadenectomy for cervical cancer:a prospective analysis of 295 patients[J].Ann Surg Oncol,2008,15(10):2847-2855.
  • 2Zivanovie O,AIektiar K,Sonoda Y,et al.Treatment patterns of FIGO Stage IB2 cervical cancclz A single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy[J].Gynecol Oncol,2008,111(2):265-270.
  • 3Ryu HS,Knng SB,Kim KT,et al.Efficacy of different types of treatment in FIGO stage IB2 cervical cancer in Korea:results of a multicenter retrospective Korean study(KGOG-1005)[J].Int J Gynecol Cancer,2007,17(1):132-136.
  • 4JeweU EL,Kulasingam S,Myers ER,et al.Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma:a cost effectiveness analysis[J].Gynecol Oncol,2007,107(3):532-540.
  • 5Zullo MA,Manci N,Angioli R,et a1.Vesical dysfunctions after radical hysterectomy for cervical cancer.a critical review[J].Crit Rev Oncol Hematol,2003,48(3):287-293.
  • 6Benedetti-Panici P,ZuUo MA,Plotti F,et al.Long-term bladder function in patients with locally advanced cervieal carcinoma treated with neoadjuvant chemotherapy and type 3-4 radical hysterectomy[J].Cancer,2004,100(10):2110-2117.
  • 7Plotti F,Zullo MA,Sansone M,et a1.Post radical hysterectomy urinary incontinence:A prospective study of transurethral bulking agents injection[J].Gyneeol Oncol,2009,112(1):90-94.
  • 8Bae JH,Lee sJ,Lee A,et al.Neoadjuvant cisplatin and etoposide followed by radical hysterectomy for stage 1B-2B cervical cancer[J].Gynecol Oncol,2008,111(3):444-448.
  • 9Choi CH,Kim TJ,Lee JW,et al.Phase II study of neoadjuvant chemotherapy with mitomycin-c,vincristine and cisplatin(MVC)in patients with stages IB2-IIB cervical carcinoma[J].Gynecol Oncol,2007,104(1):64-69.
  • 10Chen H,Liang CH,Zhang L,et al.Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced(stage IB2 to IIB)cervical cancer,A randomized study[J].Gynecol Oncol,2008,110(3):308-315.

同被引文献6

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部